insights_auto
Why is SCNI down 10,44%?
Dive Deeperchevron_right
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
0,61 $
arrow_downward
-10,44%(-0,071) 1D
0,60 $
arrow_downward
-2,33% (-0,014)bedtimeAfter hours
Closed: 21 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
0,69 $
High
0,69 $
Low
0,55 $
Mkt. cap
1,85 մլն
Avg. vol.
4,44 մլն
Volume
186,93 հզր
52-wk high
15,50 $
52-wk low
0,55 $
EPS
-2,80 $
Beta
2,13
Shares outstanding
706,59 հզր
No. of employees
45
Open
0,69 $
High
0,69 $
Low
0,55 $
Mkt. cap
1,85 մլն
Avg. vol.
4,44 մլն
Volume
186,93 հզր
52-wk high
15,50 $
52-wk low
0,55 $
EPS
-2,80 $
Beta
2,13
Shares outstanding
706,59 հզր
No. of employees
45
News stories
From web sources and news partners
Benzinga
·
1 օր առաջ
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR